- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To evaluate the immunogenicity of NNC 0129-0000-1003 (hereafter referred to as N8-GP) in previously treated patients with Haemophilia A - To evaluate the clinical efficacy of N8-GP in bleeding prophylaxis (number of bleeds during prophylaxis)
Critère d'inclusion
- Haemophilia A